Genetic Signatures Ltd has released a press release.
FDA Clearance and Capital Raising Presentation
Filed with ASX ·
Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Genetic Signatures (ASX:GSS) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Genetic Signatures Ltd. on 6ix
In the deck
Story so far
Earlier from Genetic Signatures
- Genetic Signatures Announces $30 Million Capital Raising
- Genetic Signatures Appoints Allison Rossiter As CEO
- FDA Clearance For Gastrointestinal Parasite Detection Kit
- Trading Halt
- Decision to Cease Development of US Respiratory Product
Later from Genetic Signatures
- Completion of Institutional Entitlement Offer and Placement
- Despatch Of Retail Entitlement Offer Booklet
- Appendix 4E and Annual Report
- 2024 AGM Chairman's Address and CEO Presentation
- $5m R&D Tax Incentive Received
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures